Fecal calprotectin – is it accepted by the patients?

Background:Fecal calprotectin (FC) is the most relevant inflammatory fecal biomarker in inflammatory bowel disease (IBD). This has been shown for diagnostic and monitoring issues and FC was included recently in various guidelines. To assess clinical practicability and patients acceptance to handle this stool test we retrospectively analyzed relevant parameters in a well defined IBD cohort. Methods: Over a 4 year period patients were invited after proper information to bring a stool sample to each visit. Acceptance was calculated by the relation of FC to blood CRP which was routinely measured at each visit (FC/CR…